Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) EBT Margin (2022 - 2025)

Historic EBT Margin for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Q1 2025 value amounting to 164.92%.

  • Centessa Pharmaceuticals' EBT Margin changed N/A to 164.92% in Q1 2025 from the same period last year, while for Sep 2025 it was 1595.38%, marking a year-over-year decrease of 77559600.0%. This contributed to the annual value of 2570.28% for FY2023, which is N/A changed from last year.
  • Latest data reveals that Centessa Pharmaceuticals reported EBT Margin of 164.92% as of Q1 2025.
  • In the past 5 years, Centessa Pharmaceuticals' EBT Margin ranged from a high of 3913.07% in Q2 2022 and a low of 164.92% during Q1 2025
  • For the 3-year period, Centessa Pharmaceuticals' EBT Margin averaged around 2147.61%, with its median value being 1997.43% (2023).
  • Over the last 5 years, Centessa Pharmaceuticals' EBT Margin had its largest YoY gain of -6010400bps in 2023, and its largest YoY loss of -19156400bps in 2023.
  • Centessa Pharmaceuticals' EBT Margin (Quarter) stood at 1989.88% in 2022, then tumbled by -30bps to 1388.83% in 2023, then tumbled by -112bps to 164.92% in 2025.
  • Its last three reported values are 164.92% in Q1 2025, 1388.83% for Q4 2023, and 1632.19% during Q3 2023.